verified SJR 2,489 · Q1 • database Scopus / SJR & Web of Science indexed

Japan · Springer Japan

workspace_premium Q1 — Medicine (miscellaneous) lock_open Open Access

Gastric Cancer

Gastric Cancer, a joint official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, publishes significant studies related to stomach neoplasms. The journal welcomes original articles, case reports, short communications, and techni...

ISSN: 1436-3291

Publisher: Springer Japan

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Visit publisher site menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

2,489 Q1

H-index 106

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

3.690 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

2,489

H-index

106

Docs (year)

118

Docs 3y

318

Total refs

4594

Cites 3y

2182

Citable 3y

305

Cites/Doc 2y

6.13

Ref/Doc

38.93

Immediate OA

3690 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Biomarker analysis of the GATSBY study of trastuzumab emtansine versus a taxane in previously treated HER2-positive advanced gastric/gastroesophageal junction cancer

Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer

Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: a multicenter phase I/II study

Determining prognostic factors for gastric cancer using the regression tree method

Detection of Epstein-Barr virus in gastric carcinoma cells and surrounding lymphocytes

Correction to: Oncological safety of proximal gastrectomy for T2/T3 proximal gastric cancer

Connective tissue growth factor inhibits gastric cancer peritoneal metastasis by blocking integrin a3beta1-dependent adhesion

Colliding gastric and intestinal phenotype well-differentiated adenocarcinoma of the stomach developing in an area of MALT-type lymphoma

Clinical impact of gastroenterologist-administered propofol during esophagogastroduodenoscopy: a randomized comparison at a single medical clinic

Chemosensitivity test for 5-fluorouracil and 5-chloro-2, 4-dihydroxypyridine predicts outcome of gastric cancer patients receiving S-1 postoperatively

Causation of Borrmann type 4 gastric cancer: heritable factors or environmental factors?

Carcinogenesis of gastric endocrine cell carcinoma: analysis of histopathology and p53 gene alteration

SHOW MORE ARTICLES

Biweekly administration regimen of docetaxel combined with CPT-11 in patients with inoperable or recurrent gastric cancer

A case of aggressive neuroendocrine carcinoma of the stomach

Application of reduced-port laparoscopic total gastrectomy in gastric cancer preserving the pancreas and spleen

An additional suture secures against pitfalls in delta-shaped gastroduodenostomy after laparoscopic distal gastrectomy

Always randomize as late as possible

ABO blood type, Lewis and Secretor genotypes, and chronic atrophic gastritis: a cross-sectional study in Japan

A Western single-center experience with endoscopic submucosal dissection for early gastrointestinal cancers

A phase II trial of concurrent 3D-CRT/IMRT and oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) in gastric cancer patients with R0 gastrectomy and D2 lymph node dissection

A newly modified esophagogastrostomy with a reliable angle of His by placing a gastric tube in the lower mediastinum in laparoscopy-assisted proximal gastrectomy

A new stage of sentinel node navigation surgery in early gastric cancer

A new scoring system for peritoneal metastasis in gastric cancer

A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer

FAQs

Gastric Cancer has an SJR of 2,489 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 3690 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Gastric Cancer is 25%.

Gastric Cancer

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Gastric Cancer?

What is the APC / publication cost?

What is the acceptance rate?